secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2024-07-10T23:59:59+00:00
Accession:  0001099800-24-000061
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences appoints David T. Feinberg to Board, effective July 10
---------------------------------------------------------------------------

- David T. Feinberg, M.D. appointed to Edwards Lifesciences Board and Audit Committee, effective July 10, 2024.
- Dr. Feinberg is Chairman of Oracle Health, former CEO of Cerner (acquired by Oracle in 2022).
- Previously held leadership roles at Google Health, Geisinger Health, and UCLA Health.
- Will receive standard non-employee director compensation per 2024 Proxy and standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000109980024000061/0001099800-24-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000109980024000061/ew-20240710.htm
  HTML page:      https://secwatch.observer/filing/0001099800-24-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer